Bluechiip brings wireless tracking technology to Proactive's CEO Sessions
Find out more from Andrew McLellan at Proactive's CEO Sessions.
Company
Cynata Therapeutics Ltd
ASX:CYP
Cynata Therapeutics Limited is a clinical-stage biotechnology company transforming regenerative medicine through our proprietary Cymerus™ platform technology.
39 stories · page 2 of 2
Proactive's CEO Spotlight Sessions: Cynata, Bluechiip, White Cliff, Legend Mining
Proactive's CEO Spotlight Sessions are back again giving investors the opportunity to hear the latest news flow from directors, and what to expect next.
Legend Mining brings Fraser Range nickel-copper hunt to Proactive's CEO Sessions
Find out more from Mark Wilson at Proactive's CEO Sessions.
Cynata Therapeutics talks stem cell research at Proactive's CEO Sessions
Find out more from Dr Ross Macdonald at Proactive's CEO Sessions.
Cynata Therapeutics secures funds to progress stem cell technology
Cynata Therapeutics (ASX:CYP) has successfully completed a placement to sophisticated and institutional investors to raise $6 million, at $0.65 per share.
Cynata Therapeutics to raise capital
Cynata Therapeutics (ASX:CYP) has been granted a trading halt by the ASX, pending details on a capital raising.
Cynata Therapeutics to begin stem cell product trial in England
Cynata Therapeutics (ASX:CYP) has received approval from the National Health Service (NHS), England for the Phase 1 trial in patients with steroid-resistant acute GvHD (graft versus host disease).